- Home
- USAS vs ITOS Comparison
USAS vs ITOS Comparison
Compare USAS & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USAS
- ITOS
- Stock Information
- Founded
- USAS 1998
- ITOS 2011
- Country
- USAS Canada
- ITOS United States
- Employees
- USAS N/A
- ITOS N/A
- Industry
- USAS Metal Mining
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- USAS Basic Materials
- ITOS Health Care
- Exchange
- USAS Nasdaq
- ITOS Nasdaq
- Market Cap
- USAS 286.7M
- ITOS 270.7M
- IPO Year
- USAS N/A
- ITOS 2020
- Fundamental
- Price
- USAS $0.52
- ITOS $7.32
- Analyst Decision
- USAS Strong Buy
- ITOS Strong Buy
- Analyst Count
- USAS 1
- ITOS 3
- Target Price
- USAS $0.80
- ITOS $26.00
- AVG Volume (30 Days)
- USAS 1.2M
- ITOS 349.8K
- Earning Date
- USAS 03-27-2025
- ITOS 03-05-2025
- Dividend Yield
- USAS N/A
- ITOS N/A
- EPS Growth
- USAS N/A
- ITOS N/A
- EPS
- USAS N/A
- ITOS N/A
- Revenue
- USAS $97,123,000.00
- ITOS $35,000,000.00
- Revenue This Year
- USAS $21.84
- ITOS N/A
- Revenue Next Year
- USAS $46.00
- ITOS $121.70
- P/E Ratio
- USAS N/A
- ITOS N/A
- Revenue Growth
- USAS 14.33
- ITOS 177.89
- 52 Week Low
- USAS $0.20
- ITOS $6.67
- 52 Week High
- USAS $0.60
- ITOS $18.75
- Technical
- Relative Strength Index (RSI)
- USAS 53.97
- ITOS 50.93
- Support Level
- USAS $0.45
- ITOS $6.73
- Resistance Level
- USAS $0.56
- ITOS $7.65
- Average True Range (ATR)
- USAS 0.04
- ITOS 0.39
- MACD
- USAS 0.00
- ITOS 0.04
- Stochastic Oscillator
- USAS 69.00
- ITOS 66.33
About USAS Americas Gold and Silver Corporation no par value
Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets are The Cosala operations, The Galena Complex, and Relief Canyon. The company also holds interests in the San Felipe Development Project located in Sonora, Mexico. It has geographic focus is the Western Hemisphere, particularly the United States and Mexico.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.